Concepedia

Aileen Cohen

AC

Statistics

Publications

25

Citations

2.2K

H-Index

20

Active since

1988

Affiliations

Monash University(Current)

St James's University Hospital

Dana-Farber Cancer Institute

Monash Health

Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda

Aileen Cohen is an author at Monash University specializing in medicine, pharmacology, and oncology.

Publications per year

1988–2024

25

Publications

25

Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia

Jennifer R. Brown, Barbara Eichhorst, Peter Hillmen et al. · New England Journal of Medicine · 2022 · 457 citations · Full text

, , +16

A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study

Constantine S. Tam, Stephen Opat, Shirley D’Sa et al. · Blood · 2020 · 448 citations · Full text

, , +4

Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA): a randomised, controlled, phase 3 trial

Constantine S. Tam, Jennifer R. Brown, Brad S. Kahl et al. · The Lancet Oncology · 2022 · 278 citations · Full text

, , +8

Zanubrutinib monotherapy for patients with treatment-naïve chronic lymphocytic leukemia and 17p deletion

Constantine S. Tam, Tadeusz Robak, Paolo Ghia et al. · Haematologica · 2020 · 103 citations · Full text

, , +14

Zanubrutinib Versus Ibrutinib in Symptomatic Waldenström Macroglobulinemia: Final Analysis From the Randomized Phase III ASPEN Study

Meletios Α. Dimopoulos, Stephen Opat, Shirley D’Sa et al. · Journal of Clinical Oncology · 2023 · 103 citations · Full text

, , +11

1–5 of 25